About GenBioPro
Home >
Here to Help
The original promise of medical abortion, more than 20 years ago, was that it would revolutionize reproductive health care by breaking down silos and decentralizing abortion care, making it more readily available. This promise has been slow to materialize in the US. For many years, medically unnecessary restrictions and political interference have resulted in medical abortion being inaccessible for far too many people. Limitations on abortion care training, high costs, laws banning abortion care and targeting providers, and disinformation are just some of the barriers that still constrain access to abortion care.
Yet despite these obstacles, we continue to move closer to the realization of accessible reproductive health care that is available to all who need it. With recent regulatory changes and the growing participation of prescribers and pharmacies, today medical abortion is better known, more widely available, and used by the majority of people seeking abortion care.
GenBioPro was founded on the belief that all people — regardless of income, gender, race, or geography — have a right to reproductive health care, including access to medical abortion. From driving down medication costs to promoting accurate information about abortion, our mission is to deliver affordable, effective products for people seeking abortion care.
We promote personal dignity, access to medical evidence, self-determination, and high-quality health care for all.
GenBioPro is proud to be a part of improving access to medical abortion care and to helping advance medical research to improve reproductive health. We are committed to eliminating barriers and to supporting the community of health care providers, pharmacies, patients, and advocates working to ensure universal access to reproductive health care.
Already at Work for You
We’ve been working for patients, health care providers, and pharmacies since 2012. Our market entry and competitive presence triggered changes that have benefited the community and increased access to medical abortion. Before coming to market, we advocated for reduced dosage requirements, an expanded treatment window, broader prescriber privileges, and fewer required patient visits.
We successfully obtained FDA approval in 2019 and commercialized our first generic product. In 2021, we worked with the FDA to ensure the Patient Agreement could be used by people of any gender identity. In 2022, we worked with the FDA to update prescribing guidelines, protect prescriber and patient privacy, simplify prescriber participation, and expand options for pharmacy dispensing. In 2024, we launched our second generic product, to ensure a steady, stable product supply.
Our goal has always been to drive better outcomes for patients. Going forward, we’ll continue to innovate and work for the reproductive health community at large.
We Believe
- Health care providers have had limited options for quality, reasonably priced family planning products that millions of their patients depend on. For example, until our FDA approval, there was only one option within the US for medical abortion.
- Over-regulation of medical abortion has forced doctors to spend unnecessary time and resources to prescribe and provide this care to their patients, a situation that has improved with some recent regulatory changes.
- The introduction of our generics has helped stabilize supply and satisfy the rising demand among patients for medical abortion, which has steadily increased in the US since 2000.
- A steady, reliable supply of generics for medical abortion in formats that simplify abortion care will benefit all stakeholders in the reproductive health care community.
- Our understanding of the pharmaceutical industry’s complex regulatory processes is key to identifying opportunities to increase access to safe, affordable, reproductive health care.
Building Trust: Step by Step
Our mission and values have been consistent since GenBioPro was founded. We are committed to disrupting the status quo and driving new models of reproductive health care delivery. We are standing up against abortion bans in US courts.
Evidenced by our actions to date, you can trust GenBioPro to continue to develop solutions that break new ground, bring advantage to health care providers, patients, and pharmacies, and to advocate for long-term change. We are working towards a world that ensures access to safe, affordable, reproductive health care — including medical abortion — is within reach for everyone.